Logos Global Management as of June 30, 2022
Portfolio Holdings for Logos Global Management
Logos Global Management holds 32 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 12.6 | $69M | 1.8M | 39.29 | |
| Apellis Pharmaceuticals (APLS) | 12.4 | $68M | 1.5M | 45.22 | |
| Ideaya Biosciences (IDYA) | 9.5 | $52M | 3.8M | 13.80 | |
| Design Therapeutics (DSGN) | 7.2 | $39M | 2.8M | 14.00 | |
| Sarepta Therapeutics (SRPT) | 5.5 | $30M | 400k | 74.96 | |
| Neurocrine Biosciences (NBIX) | 5.4 | $29M | 300k | 97.48 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.2 | $29M | 1.7M | 16.78 | |
| Ventyx Biosciences (VTYX) | 5.2 | $28M | 2.3M | 12.23 | |
| Horizon Therapeutics Pub L SHS | 5.1 | $28M | 350k | 79.76 | |
| Alx Oncology Hldgs (ALXO) | 4.7 | $25M | 3.1M | 8.09 | |
| Arcutis Biotherapeutics (ARQT) | 3.9 | $21M | 1.0M | 21.31 | |
| Dyne Therapeutics (DYN) | 3.7 | $20M | 2.9M | 6.87 | |
| Karuna Therapeutics Ord | 3.5 | $19M | 150k | 126.51 | |
| Dice Therapeutics | 2.8 | $15M | 985k | 15.52 | |
| Olema Pharmaceuticals (OLMA) | 2.8 | $15M | 3.7M | 4.07 | |
| Chemocentryx | 2.7 | $15M | 600k | 24.78 | |
| Fulcrum Therapeutics (FULC) | 1.8 | $9.6M | 2.0M | 4.90 | |
| ACADIA Pharmaceuticals (ACAD) | 1.7 | $9.2M | 650k | 14.09 | |
| Kezar Life Sciences | 1.4 | $7.9M | 950k | 8.27 | |
| Century Therapeutics (IPSC) | 0.7 | $4.0M | 477k | 8.40 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $1.9M | 400k | 4.87 | |
| Spruce Biosciences (SPRB) | 0.3 | $1.7M | 1.0M | 1.74 | |
| Instil Bio | 0.3 | $1.7M | 370k | 4.62 | |
| Talaris Therapeutics | 0.2 | $1.2M | 271k | 4.51 | |
| Edgewise Therapeutics (EWTX) | 0.2 | $1.2M | 150k | 7.96 | |
| Tyra Biosciences (TYRA) | 0.2 | $1.2M | 167k | 7.15 | |
| Lianbio Sponsored Ads (LIANY) | 0.2 | $852k | 395k | 2.16 | |
| Athira Pharma (ATHA) | 0.1 | $671k | 220k | 3.05 | |
| Vigil Neuroscience (VIGL) | 0.1 | $530k | 206k | 2.58 | |
| Pyxis Oncology Common Stock (PYXS) | 0.1 | $525k | 220k | 2.38 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $460k | 34k | 13.57 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $19k | 67k | 0.28 |
